In vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia

ArticleAçık Erişim

Özet

Objective: This study investigated the minimum inhibitory concentration (MIC) values and in vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia (VAP) using the E-test method. Methods: A total of 40 A. baumannii strains, identified using the Phoenix Automated Microbiology System (Becton, Dickinson and Co., Franklin Lakes, NJ, USA) by conventional methods, were included in this study. Pulsed-field gel electrophoresis was performed to examine the clonal relationships between isolates. The carbapenem resistance of the strains to colistin and tigecycline was assessed using the E-test method (Liofilchem, Roseto Degli Abruzzi, Italy). The in vitro activity of colistin in combination with tigecycline was evaluated using the fractional inhibitor concentration (FIC) index. Results: While only 1 of 40 A. baumannii strains was determined to be colistin resistant, 6 were tigecycline resistant. The MIC50, MIC90, and MIC intervals of the A. baumannii strains were 0.19, 1.5, and 0.064‒4 μg/ml for colistin and 1, 8, and 0.094‒256 μg/ml for tigecycline, respectively. No synergistic effect was observed using the FIC index; 8 strains exhibited an indifferent effect and 32 exhibited an antagonist effect. Three of the six strains that were resistant to tigecycline were indifferent; the remaining three were antagonistic. The colistin-resistant strain also exhibited an antagonist effect. Conclusion: In contrast to their synergistic effect against carbapenem-resistant A. baumannii isolates, colistin and tigecycline were highly antagonistic to carbapenem-resistant A. baumannii strains isolated from patients with VAP when the drugs were administered together. Therefore, alternative treatment options should be used during the treatment of VAP attributed to A. baumannii. © 2015 Ivyspring International Publisher.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15507Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.7150/ijms.11988Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorCikman, Aytekin
dc.contributor.authorGulhan, Baris
dc.contributor.authorAydin, Merve
dc.contributor.authorCeylan, Mehmet Resat
dc.contributor.authorParlak, Mehmet
dc.contributor.authorKarakecili, Faruk
dc.contributor.authorKaragoz, Alper
dc.date.accessioned2026-10-18T20:30:21.112351008Z
dc.date.available2026-10-18T20:30:21.112351008Z
dc.date.issued2015
dc.description.abstractObjective: This study investigated the minimum inhibitory concentration (MIC) values and in vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia (VAP) using the E-test method. Methods: A total of 40 A. baumannii strains, identified using the Phoenix Automated Microbiology System (Becton, Dickinson and Co., Franklin Lakes, NJ, USA) by conventional methods, were included in this study. Pulsed-field gel electrophoresis was performed to examine the clonal relationships between isolates. The carbapenem resistance of the strains to colistin and tigecycline was assessed using the E-test method (Liofilchem, Roseto Degli Abruzzi, Italy). The in vitro activity of colistin in combination with tigecycline was evaluated using the fractional inhibitor concentration (FIC) index. Results: While only 1 of 40 A. baumannii strains was determined to be colistin resistant, 6 were tigecycline resistant. The MIC50, MIC90, and MIC intervals of the A. baumannii strains were 0.19, 1.5, and 0.064‒4 μg/ml for colistin and 1, 8, and 0.094‒256 μg/ml for tigecycline, respectively. No synergistic effect was observed using the FIC index; 8 strains exhibited an indifferent effect and 32 exhibited an antagonist effect. Three of the six strains that were resistant to tigecycline were indifferent; the remaining three were antagonistic. The colistin-resistant strain also exhibited an antagonist effect. Conclusion: In contrast to their synergistic effect against carbapenem-resistant A. baumannii isolates, colistin and tigecycline were highly antagonistic to carbapenem-resistant A. baumannii strains isolated from patients with VAP when the drugs were administered together. Therefore, alternative treatment options should be used during the treatment of VAP attributed to A. baumannii. © 2015 Ivyspring International Publisher.
dc.identifier.doi10.7150/ijms.11988
dc.identifier.endpage700
dc.identifier.issn1449-1907
dc.identifier.issue9
dc.identifier.pmcidPMC4571546
dc.identifier.pmid26392806
dc.identifier.scopus2-s2.0-84940906758
dc.identifier.startpage695
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15507
dc.identifier.volume12
dc.identifier.wosWOS:000360296100003
dc.language.isoen
dc.publisherIvyspring International Publisher
dc.relation.ispartofInternational Journal of Medical Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAcinetobacter baumannii
dc.subjectCarbapenem-resistant
dc.subjectColistin
dc.subjectTigecycline
dc.subjectVentilator-associated pneumonia
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAnti-Bacterial Agents
dc.subjectCarbapenems
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectDrug Resistance, Bacterial
dc.subjectDrug Therapy, Combination
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMicrobial Sensitivity Tests
dc.subjectMiddle Aged
dc.subjectMinocycline
dc.subjectPneumonia, Ventilator-Associated
dc.subjectYoung Adult
dc.subjectamikacin
dc.subjectaztreonam
dc.subjectcarbapenem
dc.subjectcefepime
dc.subjectcefoperazone plus sulbactam
dc.subjectcefotaxime
dc.subjectceftazidime
dc.titleIn vitro activity of colistin in combination with tigecycline against carbapenem-resistant Acinetobacter baumannii strains isolated from patients with ventilator-associated pneumonia
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus23
rdl.citation.wos20
rdl.department1. Department of Medical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey. | 4. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)